Search filters

List of works by Lotta Hansson

Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients

scientific article published on 21 May 2014

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia.

scientific article published on 29 July 2008

Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia

scientific article published on 16 April 2016

Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies

scientific article published on 01 June 2007

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia

scientific article

Idiotype protein vaccination in combination with adjuvant cytokines in patients with multiple myeloma--evaluation of T-cell responses by different read-out systems.

scientific article published in January 2007

Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells

scientific article published on 06 February 2003

Kinetics of cytokine gene expression in human CD4+ and CD8+ T-lymphocyte subsets using quantitative real-time PCR.

scientific article published in December 2003

Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients

scientific article published on 22 May 2018

Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.

scientific article published on 3 October 2007

Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients

scientific article published on 01 March 2007

Outcomes of patients with fludarabine-refractory chronic lymphocytic leukemia: a population-based study from a well-defined geographic region

scientific article published on 04 February 2014

Outcomes of second-line treatment in chronic lymphocytic leukemia - a population-based study from a well defined geographical region between 2003 and 2013

scientific article published on 28 November 2016

Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression

scientific article published on 09 October 2012

Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints

scientific article

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group

scientific article

Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients

scientific article published on 10 August 2020

Severe infusion-related reactions are uncommon in rituximab-treated CLL patients in clinical practice: results from a Swedish national observational study

scientific article published on 13 November 2014

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia

scientific article published on 12 November 2015

T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.

scientific article

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers

scientific article

T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma

scientific article published on 06 February 2003

Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia

scientific article

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)

scientific article published on 11 January 2007

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

scientific article published on 16 November 2011

Paulina is supported by:

About Paulina

Help